“Reply to Criticism of the Paper: Critical Reappraisal of Balangero Chrysotile and Mesothelioma Risk by Magnani et Al. ”. Epidemiology, Biostatistics, and Public Health, vol. 12, no. 3, May 2022, https://doi.org/10.2427/11448.